+++++++++++++++++++++++++++++++++++++++++++++++++
Posted Tue, 5 Apr 2016 16:14:02
This message was forwarded through MEDSOCNEWS.
If you wish to make an announcement or publicise
an event then please send the text to:
[log in to unmask]
You can follow us on twitter @MedSocNews
+++++++++++++++++++++++++++++++++++++++++++++++++
Is anyone interested in, or doing research into the use of "alternative therapies" by cancer patients?
If so, I'd be delighted to hear from them.
John
John L. Anderson
Principal Lecturer/Clinical Courses Lead
Division of Medical Education - Postgraduate Medicine
Brighton & Sussex Medical School
University of Brighton
Room 344B, Mayfield House
Falmer
Brighton
BN1 9PH
Tel: 01273 644004
Fax: 01273 644002
e-mail: [log in to unmask]<mailto:[log in to unmask]>
___________________________________________________________
This email has been scanned by MessageLabs' Email Security System
on behalf of the Brighton & Sussex Medical School. For more information see:
https://staff.brighton.ac.uk/is/computing/Pages/Email/spam.aspx
**********************************************************************
1. For general enquires or problems with the list or to CHANGE YOUR EMAIL ADDRESS send a message to:
[log in to unmask]
2. To suspend yourself from the list, whilst on leave, for example,
send an email to [log in to unmask] with the following message:
set medsocnews nomail
3. To resume email from the list, send the following message:
set medsocnews mail
4. To leave MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
leave medsocnews
5. To join or subscribe to MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
SUBSCRIBE medsocnews firstname lastname
6. Further information about the medsocnews discussion list (including
list archive and how to subscribe to or leave the list) can be found
at the list web site:
http://www.jiscmail.ac.uk/lists/medsocnews.html
**********************************************************************
|